retatrutide triple agonist gip glp-1 glucagon receptor Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight retatrutide triple agonist glp-1 gip
Description
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB, Granger CB, Jones NP, et al
Efficacy of Liraglutide in Non-Diabetic Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
10.1186/s10194-023-01631-z
This change requires manufacturers to take a new approach to how they scale production
The peptide sequence contains an Aib residue at position 2, which occupies the DPP-4 binding site, conferring DPP-4 resistance
Individuals who receive GLP-1 injections must additionally monitor their blood sugar levels regularly, as these drugs might occasionally cause blood sugar to drop too low (hypoglycemia)
